Journals / Türk Kardiyoloji Derneği Arşivi / 2020 / Cilt: 48 - Sayı: 6

Positive tendency toward synchronous use of acetaminophen and ibuprofen in treating patients with patent ductus arteriosus

Patent duktus arteriyozuslu hastaların tedavisinde eş zamanlı asetaminofen ve ibuprofen kullanımına yönelik artmış eğilim

Pages
605–612
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Otherstudies with a larger sample size are recommended in orderto confirm these results

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Spontaneous closure of the ductus arteriosus often fails to occur in premature newborns and this conditioncan be associated with increased morbidity and mortality.The initial treatment to achieve closure of the opening ispharmacological, and various nonsteroidal anti-inflammatory drugs may be used.
📊
Key Findings & Data:The aim of this study was to determine whether combining acetaminophen with ibuprofen ismore effective than the individual use of these drugs to treatpatent ductus arteriosus (PDA).Methods: The present randomized, controlled trial studyincluded 154 premature newborns with PDA.
💡
Conclusion & Impact:Otherstudies with a larger sample size are recommended in orderto confirm these results
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Spontaneous closure of the ductus arteriosus often fails to occur in premature newborns and this conditioncan be associated with increased morbidity and mortality.The initial treatment to achieve closure of the opening ispharmacological, and various nonsteroidal anti-inflammatory drugs may be used. The aim of this study was to determine whether combining acetaminophen with ibuprofen ismore effective than the individual use of these drugs to treatpatent ductus arteriosus (PDA).Methods: The present randomized, controlled trial studyincluded 154 premature newborns with PDA. The patientswere randomized into 3 groups: the acetaminophen group(n=67), ibuprofen group (n=68), and combination druggroup (n=19). Echocardiography was performed before initiating the medication and after completing a first and second course of treatment. Blood markers were measured toassess the safety of the 3 types of therapy.Results: After the first course of treatment, PDA closurewas seen in 76.1% of the infants in the acetaminophengroup, 76.4% of those in the ibuprofen group, and 78.9%of the combination therapy group (p=0.97). The closure rateafter a second course of treatment was 43.7% in the acetaminophen group, 62.5% in the ibuprofen group, and 100%in the combination group. There were no complications attributed to the 3 methods of treatment used.Conclusion: Concomitant use of acetaminophen and ibuprofen can be an effective option for closure of PDA. Otherstudies with a larger sample size are recommended in orderto confirm these results

Özet

Amaç: Prematüre yenidoğanlarda duktus arteriyozusun kendiliğinden kapanması sıklıkla başarısız olur ve bu durum artmış morbidite ve mortalite ile ilişkilendirilebilir. Açıklığın kapanmasını sağlamak için ilk olarak farmakolojik tedavi uygulanmakta olup çeşitli steroid olmayan anti-enflamatuvar ilaçlar kullanılabilir. Bu çalışmanın amacı, asetaminofeni ibuprofen ile birleştirmenin patent duktus arteriyozus (PDA) tedavisinde bu ilaçların tek tek kullanımından daha etkili olup olmadığını belirlemekti. Yöntemler: Bu randomize, kontrollü çalışmaya, PDA’lı 154 prematüre yenidoğan alındı. Hastalar 3 gruba randomize edildi: Asetaminofen grubu (n=67), ibuprofen grubu (n=68) ve kombinasyon ilaç grubu (n=19). İlaca başlamadan önce ve birinci ve ikinci tedavi kürünü tamamladıktan sonra ekokardiyografi yapıldı. Üç tedavi yönteminin güvenliğini değerlendirmek için kan belirteçleri ölçüldü. Bulgular: İlk tedavi küründen sonra asetaminofen grubundaki bebeklerin %76.1’inde, ibuprofen grubundakilerin %76.4’ünde ve kombinasyon tedavi grubunun %78.9’unda PDA’nın kapandığı görüldü (p=0.97). İkinci bir tedavi küründen sonra kapanma oranı asetaminofen grubunda %43.7, ibuprofen grubunda %62.5 ve kombinasyon grubunda %100 idi. Kullanılan üç tedavi yöntemine ilişkin herhangi bir komplikasyon yoktu. Sonuç: Asetaminofen ve ibuprofenin birlikte kullanımı PDA’nın kapatılmasında etkili bir seçenek olabilir. Bu sonuçları doğrulamak için daha büyük örneklem büyüklüğüne sahip başka çalışmaların yürütülmesi tavsiye edilir.

🔖

Cite This Article

MOGHTADERI, M., OBOODI, R., NAJIB, K. S., AMOOZGAR, H., MEHDIZADEGAN, N., POURARIAN, S., SABZEVARI, F. (2022). Positive tendency toward synchronous use of acetaminophen and ibuprofen in treating patients with patent ductus arteriosus. Türk Kardiyoloji Derneği Arşivi, Cilt: 48 - Sayı: 6, 605–612. https://ajindex.com/articles/631996

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Weichert J, Hartge DR, Axt-Fliedner R. The fetal ductus arteriosus and its abnormalities-a review. Congenit Heart Dis 2010;5:398–408
  2. Gournay V. The ductus arteriosus: physiology, regulation, and functional and congenital anomalies. Arch Cardiovasc Dis 2011;104:578–85
  3. Kluckow M, Evans N. Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J Pediatr 2000;137:68–72
  4. Clyman RI. Mechanisms regulating the ductus arteriosus. Biol Neonate 2006;89:330–5
  5. Pourarian S, Farahbakhsh N, Sharma D, Cheriki S, Bijanzadeh F. Prevalence and risk factors associated with the patency of ductus arteriosus in premature neonates: a prospective observational study from Iran. J Matern Fetal Neonatal Med 2017;30:1460–4
  6. Bardanzellu F, Neroni P, Dessì A, Fanos V. Paracetamol in Patent Ductus Arteriosus Treatment: Efficacious and Safe?. Biomed Res Int 2017;2017:1438038
  7. Sivanandan S, Agarwal R. Pharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration. Paediatr Drugs 2016;18:123–38
  8. Ahamed MF, Verma P, Lee S, Vega M, Wang D, Kim M, et al. Predictors of successful closure of patent ductus arteriosus with indomethacin. J Perinatol 2015;35:729–34
  9. Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database Syst Rev 2018;9:CD003481
  10. O’Brien WF, Krammer J, O’Leary TD, Mastrogiannis DS. The effect of acetaminophen on prostacyclin production in pregnant women. Am J Obstet Gynecol 1993;168:1164–9
  11. Vaidya R, Wilson D, Paris Y, Madore L, Singh R. Use of acetaminophen for patent ductus arteriosus treatment: a single center experience. J Matern Fetal Neonatal Med 2019:1–7
  12. Yang B, Gao X, Ren Y, Wang Y, Zhang Q. Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: A randomized controlled trial. Exp Ther Med 2016;12:2531–6
  13. Yurttutan S, Oncel MY, Arayicı S, Uras N, Altug N, Erdeve O, et al. A different first-choice drug in the medical management of patent ductus arteriosus: oral paracetamol. J Matern Fetal Neonatal Med 2013;26:825–7
  14. Dang D, Wang D, Zhang C, Zhou W, Zhou Q, Wu H. Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PLoS One 2013;8:e77888
  15. Arlettaz R. Echocardiographic Evaluation of Patent Ductus Arteriosus in Preterm Infants. Front Pediatr 20